Loading…
UTI - Pharma & Healthcare Fund
Disclosed for 41 months, Jan 2014 to Jun 2017. This scheme is no longer reporting.
Portfolio value
₹304 Cr
up ₹25.1 Cr vs Jul 2015
- Stocks held
- 25
- up 2 vs Jul 2015
- Top 10 weight
- 74.0%
- of the portfolio in its ten largest
- Cash & debt
- 10.7%
- cash, money market and debt
- Moves this month
- 2 in · 0 out
- added to 10, trimmed 10
UTI - Pharma & Healthcare Fund is an active equity fund in the Sectoral / Thematic category from UTI Mutual Fund. In August 2015 it disclosed 25 stocks worth ₹304 Cr, up ₹25.1 Cr from Jul 2015. Its largest positions were Sun Pharmaceutical Industries Limited (18.3%), Dr. Reddy's Laboratories Limited (13.7%), Lupin Limited (10.7%); the ten largest together made up 74.0% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 92.0% of its equity. Cash and debt stood at 10.7%. Compared with Jul 2015 the fund entered 2 new stocks and exited 0.
Against 227 other Sectoral / Thematic funds
Concentration
96%
Top-10 weight is higher than 96% of peers
Breadth
7%
Holds more stocks than 7% of peers
Cash
96%
Holds more cash than 96% of peers
Holdings in August 2015
Download CSVEvery line the fund disclosed, with the change against Jul 2015. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 18.35%
- Δ weight
- up 1.02 pts
- Value
- ₹55.7 Cr
- Δ value
- up ₹7.4 Cr
- Status
- Added
- Weight
- 13.66%
- Δ weight
- down 0.45 pts
- Value
- ₹41.5 Cr
- Δ value
- up ₹2.2 Cr
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 10.72%
- Δ weight
- up 1.20 pts
- Value
- ₹32.5 Cr
- Δ value
- up ₹6 Cr
- Status
- Added
- Weight
- 10.67%
- Δ weight
- up 0.47 pts
- Value
- ₹32.4 Cr
- Δ value
- up ₹4 Cr
- Status
- Added
- Weight
- 9.18%
- Δ weight
- down 0.62 pts
- Value
- ₹27.9 Cr
- Δ value
- up ₹58 L
- Status
- Added
- Weight
- 5.23%
- Δ weight
- down 0.52 pts
- Value
- ₹15.9 Cr
- Δ value
- down ₹15 L
- Status
- Trimmed
- Weight
- 5.05%
- Δ weight
- down 0.68 pts
- Value
- ₹15.3 Cr
- Δ value
- down ₹63 L
- Status
- Trimmed
- Weight
- 4.32%
- Δ weight
- up 0.19 pts
- Value
- ₹13.1 Cr
- Δ value
- up ₹1.6 Cr
- Status
- Added
- Weight
- 2.73%
- Δ weight
- down 0.23 pts
- Value
- ₹8.3 Cr
- Δ value
- up ₹5 L
- Status
- Added
- Weight
- 2.49%
- Δ weight
- up 0.17 pts
- Value
- ₹7.5 Cr
- Δ value
- up ₹1.1 Cr
- Status
- Added
- Weight
- 2.35%
- Δ weight
- down 0.46 pts
- Value
- ₹7.1 Cr
- Δ value
- down ₹70 L
- Status
- Trimmed
- Weight
- 2.25%
- Δ weight
- down 0.01 pts
- Value
- ₹6.8 Cr
- Δ value
- up ₹54 L
- Status
- Added
- Weight
- 1.93%
- Δ weight
- down 0.52 pts
- Value
- ₹5.9 Cr
- Δ value
- down ₹96 L
- Status
- Trimmed
- Weight
- 1.69%
- Δ weight
- down 0.21 pts
- Value
- ₹5.1 Cr
- Δ value
- down ₹16 L
- Status
- Trimmed
- Weight
- 1.43%
- Δ weight
- down 0.19 pts
- Value
- ₹4.3 Cr
- Δ value
- down ₹16 L
- Status
- Trimmed
- Weight
- 1.07%
- Δ weight
- up 0.61 pts
- Value
- ₹3.2 Cr
- Δ value
- up ₹2 Cr
- Status
- Added
- Weight
- 1.01%
- Δ weight
- down 0.14 pts
- Value
- ₹3.1 Cr
- Δ value
- down ₹13 L
- Status
- Trimmed
- Weight
- 0.98%
- Δ weight
- up 0.98 pts
- Value
- ₹3 Cr
- Δ value
- up ₹3 Cr
- Status
- New
- Weight
- 0.90%
- Δ weight
- down 0.11 pts
- Value
- ₹2.7 Cr
- Δ value
- down ₹7 L
- Status
- Trimmed
- Weight
- 0.88%
- Δ weight
- down 0.03 pts
- Value
- ₹2.7 Cr
- Δ value
- up ₹15 L
- Status
- Added
- Weight
- 0.82%
- Δ weight
- down 0.15 pts
- Value
- ₹2.5 Cr
- Δ value
- down ₹22 L
- Status
- Trimmed
- Weight
- 0.75%
- Δ weight
- up 0.02 pts
- Value
- ₹2.3 Cr
- Δ value
- up ₹24 L
- Status
- Added
- Weight
- 0.73%
- Δ weight
- down 0.02 pts
- Value
- ₹2.2 Cr
- Δ value
- up ₹12 L
- Status
- Added
- Weight
- 0.49%
- Δ weight
- down 0.42 pts
- Value
- ₹1.5 Cr
- Δ value
- down ₹1.1 Cr
- Status
- Trimmed
- Weight
- 0.24%
- Δ weight
- up <0.01 pts
- Value
- ₹73 L
- Δ value
- up ₹7 L
- Status
- Added
- Weight
- 0.09%
- Δ weight
- up 0.09 pts
- Value
- ₹27 L
- Δ value
- up ₹27 L
- Status
- New
What changed, Jul 2015 to Aug 2015
New New positions (2)
- Indraprastha Medical Corporation Limited1.0% · ₹3 Cr
- Syngene International Limited0.1% · ₹27 L
Exited Exited (0)
None.
Added Biggest additions
- Sun Pharmaceutical Industries Limitedup ₹7.4 Cr (+1.02% pts)
- Lupin Limitedup ₹4 Cr (+0.47% pts)
- Dr. Reddy's Laboratories Limitedup ₹2.2 Cr (−0.45% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jul 2015, the weight rose most in Healthcare Services (+1.2 pts), and fell most in Pharmaceuticals & Biotechnology (−0.7 pts) and Pharmaceuticals (−0.5 pts).
- Healthcare Services0.0% → 1.2%new+1.2 pts
- Pharmaceuticals & Biotechnology92.7% → 92.0%−0.7 pts
- Pharmaceuticals6.3% → 5.9%−0.5 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Aug 2014 | Feb 2015 | Apr 2015 | Jul 2015 | Aug 2015 |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 85.5% | 86.8% | 92.3% | 92.7% | 92.0% |
| Pharmaceuticals | 13.5% | 12.1% | 6.5% | 6.3% | 5.9% |
| Healthcare Services | — | — | — | — | 1.2% |
| Finance | 1.0% | 1.1% | 1.1% | 1.0% | 1.0% |
Allocation in Aug 2015change vs Jul 2015
- Pharmaceuticals & Biotechnology (17)92.0%▼ 0.7 pts
- Pharmaceuticals (5)5.9%▼ 0.5 pts
- Healthcare Services (2)1.2%▲ 1.2 pts
- Finance (1)1.0%
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Aug 2015
10.7%
▲ 1.2 pts vs Jul 2015
- Cash alone
- 10.7%
- cash and net receivables
- A year earlier
- 2.1%
- Aug 2014 · now ▲ 8.6 pts
- Last 12 months
- 5.3% – 10.7%
- lowest to highest · record 11.6% in Mar 2014
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.